Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2018421rdf:typepubmed:Citationlld:pubmed
pubmed-article:2018421lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:2018421lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:2018421lifeskim:mentionsumls-concept:C0014806lld:lifeskim
pubmed-article:2018421lifeskim:mentionsumls-concept:C0444720lld:lifeskim
pubmed-article:2018421pubmed:issue1lld:pubmed
pubmed-article:2018421pubmed:dateCreated1991-5-20lld:pubmed
pubmed-article:2018421pubmed:abstractTextA 8 day-old full-term newborn showed severe cardiac disturbances after intravenous injection of erythromycin. The neonate, suspected of having Chlamydia pneumonitis because of tachypnea and rhinitis, had been given 5 injections of erythromycin without clinical effect. Pallor, vomiting and bradycardia developed a few minutes after the 6th injection, and ECG showed ventricular arrhythmia, prolonged QT interval and an atrioventricular block. The infant died in intensive care unit. This case and the analysis of other published cases of cardiac disturbances following the parenteral use of erythromycin, indicate the potential arrhythmogenic risk of this drug. It is suggested that newborns treated with erythromycin should be monitored by ECG.lld:pubmed
pubmed-article:2018421pubmed:languagefrelld:pubmed
pubmed-article:2018421pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2018421pubmed:citationSubsetIMlld:pubmed
pubmed-article:2018421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2018421pubmed:statusMEDLINElld:pubmed
pubmed-article:2018421pubmed:monthJanlld:pubmed
pubmed-article:2018421pubmed:issn0003-9764lld:pubmed
pubmed-article:2018421pubmed:authorpubmed-author:BadoualJJlld:pubmed
pubmed-article:2018421pubmed:authorpubmed-author:BenoitAAlld:pubmed
pubmed-article:2018421pubmed:authorpubmed-author:ChecouryAAlld:pubmed
pubmed-article:2018421pubmed:authorpubmed-author:BavouxFFlld:pubmed
pubmed-article:2018421pubmed:authorpubmed-author:VillainEElld:pubmed
pubmed-article:2018421pubmed:authorpubmed-author:BodiouCClld:pubmed
pubmed-article:2018421pubmed:issnTypePrintlld:pubmed
pubmed-article:2018421pubmed:volume48lld:pubmed
pubmed-article:2018421pubmed:ownerNLMlld:pubmed
pubmed-article:2018421pubmed:authorsCompleteYlld:pubmed
pubmed-article:2018421pubmed:pagination39-41lld:pubmed
pubmed-article:2018421pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2018421pubmed:meshHeadingpubmed-meshheading:2018421-...lld:pubmed
pubmed-article:2018421pubmed:meshHeadingpubmed-meshheading:2018421-...lld:pubmed
pubmed-article:2018421pubmed:meshHeadingpubmed-meshheading:2018421-...lld:pubmed
pubmed-article:2018421pubmed:meshHeadingpubmed-meshheading:2018421-...lld:pubmed
pubmed-article:2018421pubmed:meshHeadingpubmed-meshheading:2018421-...lld:pubmed
pubmed-article:2018421pubmed:meshHeadingpubmed-meshheading:2018421-...lld:pubmed
pubmed-article:2018421pubmed:year1991lld:pubmed
pubmed-article:2018421pubmed:articleTitle[QT prolongation and circulatory arrest after an injection of erythromycin in a newborn infant].lld:pubmed
pubmed-article:2018421pubmed:affiliationService de Pédiatrie B, Hôpital Saint-Vincent-de-Paul, Paris.lld:pubmed
pubmed-article:2018421pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2018421pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:2018421pubmed:publicationTypeReviewlld:pubmed